Buchholz
TL2 Member · Pisa, IT
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 6 May 2025 · last posted 1d
90 posts, newest first. Showing up to 150.
-
[2026 update] Documenting an adverse event properly Replied, post #23 · Safety › Adverse events · 27 Jul 2026 · 5 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Seven-day rolling means and why weekly readings mislead Replied, post #113 · Outcomes › Progress reports · 26 Jul 2026 · 19 likes On post #109 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
CJC-1295 with and without DAC: what the modification does Replied, post #119 · Compounds › Secretagogues & GH axis · 22 Jul 2026 · 3 likes post #118 answers the question as asked. The question underneath it is different. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #80 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #87 · Start Here › Welcome · 16 Jul 2026 · 1 like Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #22 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Forced degradation studies: designing one that is informative Replied, post #94 · Analytics › Method validation · 9 Jul 2026 · 10 likes post #93 is right about the mechanism and I think understates the practical bit. Stability-indicating method: one that can separate a compound from its degradation…
-
Journal club: STEP 1 and the treatment-policy estimand Replied, post #2 · Evidence › Journal club · 8 Jul 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Why this subcategory is stricter about sourcing than most Replied, post #48 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 20 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #30 · Documentation › Doc review · 26 Jun 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Citation checking: if a maintained page cites a paper, the citation should match…
-
Search filters: what is missing Replied, post #70 · Meta › Site feedback · 17 Jun 2026 · 0 likes This follows post #67 rather than contradicting it. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation…
-
Why the timeline is on the right and not the left — what changed since Replied, post #56 · Meta › Site feedback · 17 Jun 2026 · 2 likes Worth separating two things that post #52 runs together. Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to…
-
Second pass at: Programming during a large energy deficit Replied, post #28 · Nutrition & Training › Resistance training · 15 Jun 2026 · 8 likes Worth separating two things that post #24 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #2 · Analytics › Home & field testing · 2 Jun 2026 · 29 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Blinding yourself: practical methods and their limits Replied, post #28 · Research Methods › N-of-1 designs · 24 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #39 · Practice › Dosing & titration · 20 May 2026 · 12 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #45 · Practice › Interactions · 16 May 2026 · 0 likes Coming back to post #43, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Reading a home test result without over-claiming Replied, post #35 · Analytics › Home & field testing · 8 May 2026 · 16 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #52 · Practice › Administration · 16 Apr 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Absolute versus relative contraindications Replied, post #66 · Safety › Contraindications · 14 Apr 2026 · 13 likes Severe renal impairment (eGFR
-
Spreadsheets: an appreciation — what changed since Replied, post #18 · Lounge › Off topic · 13 Apr 2026 · 5 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
When a dose reduction is the correct response to a side effect Replied, post #7 · Practice › Dosing & titration · 22 Mar 2026 · 19 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
A staff appointment, and what the role involves Replied, post #3 · Meta › Announcements · 19 Mar 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. When announcements are made: major policy changes, technical changes affecting site…
-
Measurement error in a self-reported exposure Replied, post #102 · Evidence › Study critique · 27 Feb 2026 · 18 likes post #101 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Measurement error in a self-reported exposure Replied, post #99 · Evidence › Study critique · 26 Feb 2026 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #5 · Evidence › Journal club · 22 Feb 2026 · 10 likes On the opening post — agreed on the reasoning, with one qualification. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
EU-wide position versus national implementation — what changed since Replied, post #17 · Regional › European Union · 20 Feb 2026 · 26 likes France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
-
Follow-up: Search filters: what is missing Replied, post #36 · Meta › Site feedback · 18 Feb 2026 · 2 likes This follows post #33 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #92 · Analytics › Mass spectrometry · 15 Feb 2026 · 10 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #77 · Analytics › Mass spectrometry · 14 Feb 2026 · 26 likes post #76 is right about the mechanism and I think understates the practical bit. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Coming back to: Training through a dose escalation week Replied, post #20 · Nutrition & Training › Resistance training · 2 Feb 2026 · 30 likes post #19 is right about the mechanism and I think understates the practical bit. Programming while losing weight quickly: realistic expectations are crucial. Strength…
-
About the Bloodwork category Replied, post #3 · Clinical › Bloodwork · 26 Jan 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Absence of evidence and evidence of absence Replied, post #12 · Research Methods › Statistics · 7 Jan 2026 · 30 likes On post #8 — agreed on the reasoning, with one qualification. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #12 · Practice › Storage & stability · 1 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Adolescents: a distinct evidence base — one year on Replied, post #49 · Clinical › Special populations · 31 Dec 2025 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #8 · Sourcing › Payments · 28 Dec 2025 · 16 likes On post #4 — agreed on the reasoning, with one qualification. Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for…
-
About the Other compounds category Replied, post #13 · Compounds › Other compounds · 26 Dec 2025 · 3 likes post #12 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #10 · Compounds › Semaglutide · 18 Nov 2025 · 30 likes Coming back to post #8, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
Gauge and length selection for subcutaneous injection Replied, post #48 · Devices › Syringes & needles · 8 Nov 2025 · 19 likes post #47 answers the question as asked. The question underneath it is different. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
-
Reading an interaction checker output critically Replied, post #33 · Practice › Interactions · 31 Oct 2025 · 30 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #80 · Documentation › Doc review · 24 Oct 2025 · 29 likes Picking up post #77: that is the part I would want checked first. Multilingual versions: if a maintained page should exist in another language, suggesting it here with…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #30 · Compounds › Semaglutide · 20 Oct 2025 · 23 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
New subcategory: rationale and scope Replied, post #44 · Meta › Announcements · 17 Oct 2025 · 6 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #11 · Evidence › Journal club · 17 Oct 2025 · 23 likes This follows post #8 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #32 · Start Here › Welcome · 15 Oct 2025 · 2 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #36 · Wellbeing › Mental health · 11 Oct 2025 · 4 likes I read post #34 twice before replying, because I had assumed the opposite. When to involve a professional: if mood changes are persistent, deepen over weeks, or…
-
Airline travel with a temperature-sensitive injectable Replied, post #7 · Devices › Cold chain · 10 Oct 2025 · 30 likes Picking up post #4: that is the part I would want checked first. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #113 · Compounds › Retatrutide · 18 Sep 2025 · 13 likes post #112 answers the question as asked. The question underneath it is different. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #73 · Evidence › Study critique · 14 Sep 2025 · 6 likes post #72 answers the question as asked. The question underneath it is different. Defending a paper against criticism: if the authors respond, they might clarify…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #11 · Meta › Announcements · 14 Sep 2025 · 17 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Tracking that stops updating and then resumes — the long version Replied, post #11 · Sourcing › Logistics · 3 Sep 2025 · 0 likes Picking up post #8: that is the part I would want checked first. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #17 · Lounge › Off topic · 2 Sep 2025 · 6 likes On post #13 — agreed on the reasoning, with one qualification. Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
[2026 update] Splitting an overlong document into two Replied, post #28 · Documentation › Wiki requests · 29 Aug 2025 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #94 · Access › Insurance & coverage · 26 Aug 2025 · 0 likes post #93 answers the question as asked. The question underneath it is different. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #92 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Are there stupid questions here? A staff answer, at length Replied, post #87 · Start Here › Welcome · 18 Aug 2025 · 4 likes On post #83 — agreed on the reasoning, with one qualification. The compound and evidence pages are updated regularly and they are worth reading when you are new. They…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #55 · Evidence › Journal club · 17 Aug 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #77 · Access › Insurance & coverage · 12 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A ten-fold dose error caught before injection — one year on Replied, post #52 · Devices › Syringes & needles · 2 Aug 2025 · 25 likes post #51 answers the question as asked. The question underneath it is different. Sharps disposal: needles and syringes should be disposed in a sharps container (a…
-
Coming back to: Official shortage notices and what they authorise Replied, post #70 · Access › Shortages · 27 Jul 2025 · 3 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Appeal templates and why they are deliberately unemotional — one year on Started this topic · Access › Insurance & coverage · 13 Jul 2025 · 12 likes Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. Documenting…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #16 · Evidence › Journal club · 23 Jun 2025 · 6 likes Picking up post #13: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #12 · Compounds › Semaglutide · 31 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #27 · Devices › Cold chain · 13 May 2025 · 3 likes I read post #25 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #62 · Compounds › Secretagogues & GH axis · 27 Apr 2025 · 10 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Residual solvents and scavengers: what is looked for Replied, post #16 · Analytics › Impurities & related substances · 24 Apr 2025 · 5 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #87 · Compounds › Semaglutide · 22 Apr 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #19 · Practice › Reconstitution · 11 Apr 2025 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #4 · Analytics › Home & field testing · 4 Apr 2025 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Started this topic · Evidence › Journal club · 29 Mar 2025 · 4 likes Posting this under the heading it deserves: Journal club: indirect comparison between two programmes, defended and attacked — one year on Everything below is what sits…
-
Reading order for a first week here, and what to skip until later Replied, post #57 · Start Here › Welcome · 29 Mar 2025 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Transit times by route, from a logged dataset — the long version Replied, post #65 · Sourcing › Logistics · 28 Feb 2025 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #108 · Data & Tools › Calculators · 27 Feb 2025 · 2 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Second pass at: Regression to the mean in progress reports Replied, post #58 · Research Methods › Statistics · 17 Feb 2025 · 20 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Protein density versus volume when you cannot eat much Replied, post #87 · Nutrition & Training › Protein & intake · 7 Feb 2025 · 7 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Protein density versus volume when you cannot eat much Replied, post #62 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 8 likes On post #58 — agreed on the reasoning, with one qualification. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #107 · Analytics › Method validation · 31 Dec 2024 · 9 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #29 · Compounds › Oral incretins · 26 Dec 2024 · 32 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
A page that has drifted out of date and needs a maintainer Replied, post #38 · Documentation › Wiki requests · 10 Dec 2024 · 0 likes post #37 answers the question as asked. The question underneath it is different. Authority and authorship: if you think a maintained page needs input from someone with…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #18 · Practice › Side effects · 22 Nov 2024 · 5 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Time to steady state after a dose increase Replied, post #10 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Buffers, pH and why a formulation is a formulation Started this topic · Pharmacology › Formulation chemistry · 24 Oct 2024 · 7 likes Buffers, pH and why a formulation is a formulation Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #50 · Clinical › Comorbidities · 17 Oct 2024 · 7 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Why a preprint's supplementary material is often the best part Replied, post #20 · Evidence › Preprints · 11 Sep 2024 · 17 likes On post #16 — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #43 · Analytics › COA interpretation · 2 Sep 2024 · 3 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #22 · Evidence › Preprints · 2 Aug 2024 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Always label it as a preprint in any discussion. A preprint is not a published…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #14 · Sourcing › Red flags · 27 Jul 2024 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Anonymity: a supplier that will not disclose legal name, address, or responsible…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #56 · Practice › Dosing & titration · 22 Jul 2024 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Second pass at: Retatrutide dose escalation in the published trials Started this topic · Compounds › Retatrutide · 14 Jul 2024 · 48 likes Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J…
-
Second pass at: Albumin binding and how it produces a long half-life Started this topic · Pharmacology › Pharmacokinetics · 22 Jun 2024 · 22 likes Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. I would like…